Ultra-Small Solid Archaeolipid Nanoparticles for Active Targeting to Macrophages of the Inflamed Mucosa

What is it about?

Solid archaeolipid nanoparticles, by merging high endurance against destructive agents in the gastrointestinal tract with an extensive uptake by macrophages and negative charge surface may be well suited for oral targeted delivery to the inflamed mucosa

Featured Image